Proof of Efficacy, Maintenance of Efficacy, Long-term Safety and Investigation of the Potential for Dependence and Abuse and the Effect of Abrupt Drug Withdrawal of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain
Latest Information Update: 01 Jul 2024
At a glance
- Drugs Dronabinol (Primary)
- Indications Back pain
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Vertanical
- 30 Jun 2024 This trial has been completed in Austria, according to European Clinical Trials Database record.
- 05 Apr 2024 Status changed from recruiting to completed.
- 04 May 2023 Planned End Date changed from 28 Dec 2023 to 27 May 2024.